About
Qlaris Bio is a clinical-stage biotechnology company developing innovative first-in-class therapies to treat ophthalmic diseases such as glaucoma by lowering intraocular pressure through a novel mechanism of action.
Explore Qlaris Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.